Dynamin Is Required for Recombinant Adeno-Associated Virus Type 2 Infection

Recombinant adeno-associated virus (rAAV) vectors for gene therapy of inherited disorders have demonstrated considerable potential for molecular medicine. Recent identification of the viral receptor and coreceptors for AAV type 2 (AAV-2) has begun to explain why certain organs may demonstrate higher...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Duan, Dongsheng, Li, Qiang, Kao, Aimee W., Yue, Yongping, Pessin, Jeffrey E., Engelhardt, John F.
Formato: Artigo
Idioma:Inglês
Publicado: American Society for Microbiology 1999
Assuntos:
Gene Therapy
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC113092/
https://ncbi.nlm.nih.gov/pubmed/10559355
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares